Quest Diagnostics Inc $61.46

up +0.71


22/7/2014 11:30 AM  |  NYSE : DGX  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get DGX Trend Analysis - it has underperformed the S&P 500 by 14%

Partner Headlines

  1. Analyzing Stock Buybacks For Value Creation

    YCharts
  2. Top Five Guru-Owned Mid Cap Stocks

    GuruFocus
  3. Bloody Disruption: New Threat to Quest, LabCorp

    YCharts
  4. Mid-Day Market Movers For Monday, June 16, 2014

    Benzinga
  5. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  6. Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S

    GuruFocus
  7. UPDATE: Bank Of America Upgrades Quest Diagnostics On Near-Term Outlook

    Benzinga
  8. Benzinga's Top Upgrades

    Benzinga
  9. Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B

    GuruFocus
  10. Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S

    GuruFocus
  11. Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B

    GuruFocus
  12. Tool: Find Stocks Benefitting From Smart Buybacks

    YCharts
  13. Earnings Scheduled For April 24, 2014

    Benzinga
  14. Quest Diagnostics Extends Partnership with Steward Health Care System

    Benzinga
  15. Medical Diagnostic Labs Facing Medicare Headwinds

    GuruFocus
  16. Morning Coffee: Stocks at Historical Low P/B and P/S

    GuruFocus
  17. Myriad Stock Tumbles After Court Allows Rival To Sell

    IBD
  18. US Stock Futures Edge Lower Ahead Of Wholesale Trade Data

    Benzinga
  19. Diamond Hill Capital Comments on Quest Diagnostics

    GuruFocus
  20. Stocks Hitting 52-Week Lows

    Benzinga
  21. UPDATE: Quest Diagnostics Posts Higher Q4 Profit, Issues Downbeat 2014 ...

    Benzinga
  22. Earnings Scheduled For January 30, 2014

    Benzinga
  23. Quest Buys Solstas Lab for $570M

    FoxBusiness
  24. It's Time to Follow Chris Davis and Buy Laboratory Corp

    GuruFocus
  25. Quest Diagnostics Adds Timothy L. Main to Board of Directors

    Benzinga
  26. UC San Francisco, Quest Diagnostics Form Collaboration

    Benzinga
  27. Myriad Price Cut Reflects Changing Gene-Test Industry

    IBD
  28. 5 Leadership Traits That Stock Investors Should Look For

    GuruFocus
  29. Numerous Gurus Hold IDCC, DGX, PTR at 10-Year Low P/B

    GuruFocus
  30. Myriad Hit By Downgrades After Reimbursement Cut

    IBD
  31. UPDATE: JMP Securities Initiates Coverage on Quest Diagnostics on Multiple ...

    Benzinga
  32. Hologic's Opportunity (Icahn Sees It. Do You?)

    GuruFocus
  33. DGX, STO, LSE:DOM - Gurus Hold Stocks Traded at 10-Year Low P/B

    GuruFocus
  34. Quest, LabCorp Plunge: Buying Opportunity?

    YCharts
  35. UPDATE: Morgan Stanley Removes PT on Quest Diagnostics on Model Update ...

    Benzinga
  36. UPDATE: Bank of America Downgrades Quest Diagnostics on Reduced 2014 EPS ...

    Benzinga
  37. Benzinga's Top Downgrades

    Benzinga
  38. Myriad Genetics Sued On Gene Patents; Stock Falls

    IBD
  39. Dividends Are Still The Yield That Matters

    YCharts
  40. Benzinga's Top Initiations

    Benzinga
  41. Danaher Hits New High After Q3 Earnings Beat

    IBD
  42. Earnings Scheduled For October 17, 2013

    Benzinga
  43. J&J Q3 Results: Strong In Pharma, So-So Elsewhere

    IBD
  44. UPDATE: Citigroup Lowers PT on Quest Diagnostics Following Disappointing ...

    Benzinga
  45. Disappointing Preliminary Earnings from Quest Diagnostics Trickles Down ...

    Benzinga
  46. Quest Acquires ConVerge Diagnostic Services

    Benzinga
  47. Myriad Genetics Falls On Downgrade, Despite Q4 Beat

    IBD
  48. Royalty Pharma Partners with Aisling Capital and Clarus Ventures in Recent ...

    Benzinga
  49. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry ...

    Benzinga
  50. Benzinga Market Primer: Wednesday, January 23

    Benzinga
Trading Center